Search
for
Sort by
Research 481–510 of 1000+
- 0952 Spatial transcriptomics reveal compartmentalized dysregulation of lipid metabolism in acne vulgaris
- Case report: Dupilumab therapy for alopecia areata in a 4-year-old patient resistant to baricitinib
- Distribution of human B-defensin 2, TNF-alpha, IL-1 alpha, IL-6 and IL-8 in psoriatic skin
- UVB-induced depletion of donor-derived dendritic cells prevents allograft rejection of immune-privileged hair follicles in humanized mice
- JAK inhibitors in dermatology: The promise of a new drug class
- Clinical and Immunological Phenotype of Patients With Primary Immunodeficiency Due to Damaging Mutations in NFKB2
- Profile of tofacitinib citrate and its potential in the treatment of moderate-to-severe chronic plaque psoriasis
- Second International Symposium—Epigenetic Regulation of Skin Regeneration and Aging: From Chromatin Biology towards the Understanding of Epigenetic Basis of Skin Diseases
- Modulating the Gut–Skin Axis in Dermatological Diseases: Mechanisms and Clinical Applications of Probiotics, Prebiotics, Synbiotics, and Postbiotics
- Immune-Mediated Skin Reactions Induced by Recombinant Antibodies and Other TNF-Alpha Inhibitors
- The Role of Vitamin D in Autoimmune Thyroid Diseases: From Immunomodulation to Clinical Implications
- Feeding the skin: The emerging role of nutritional intervention in dermatological disorders
- Dual Relief: How Atopic Dermatitis Treatments Affect Alopecia Areata—A Small Retrospective Cohort Study
- Alopecia Areata in Latin America: Where are We and Where are We Going?
- Hypothesis: platelet-rich plasma as an adjunct therapy for eczema targeting inflammation, skin barrier repair, and chronic recurrence
- “<i>Nomen Omen</i>: The Myth of God Janus”
- Drug-induced alopecia after dupilumab therapy
- Tregs: Where We Are and What Comes Next?
- Diverse Role of OX40 on T Cells as a Therapeutic Target for Skin Diseases
- The Immunological Impact of IL-1 Family Cytokines on the Epidermal Barrier
- IL-12/IL-23 neutralization is ineffective for alopecia areata in mice and humans
- Erlotinib-Induced Skin Inflammation Is IL-1 Mediated in KC-Tie2 Mice and Human Skin Organ Culture
- Probiotics in Dermatology: An Evidence-based Approach
- Halo naevi, vitiligo and diffuse alopecia areata associated with tocilizumab therapy
- Autophagy: Guardian of Skin Barrier
- The Role of the Microbiome in the Resolution of Infection-Induced Inflammation
- Efficacy of Upadacitinib in Treating Alopecia Areata, Atopic Dermatitis, and Th1 Comorbidities in Pediatric Patients: A Comprehensive Case Series and Literature Review
- The expanding impact of T-regs in the skin
- Off-label dermatologic uses of IL-23 inhibitors
- Adenosine and Its Receptors in the Pathogenesis and Treatment of Inflammatory Skin Diseases